Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 6
Submit an article Journal homepage
6,349
Views
13
CrossRef citations to date
0
Altmetric
Review

Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward

Vipin M. Vashishthaa Department of Pediatrics, Mangla Hospital & Research Center, Shakti Chowk, Bijnor, IndiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1097-117X
ORCID Icon &
Puneet Kumarb Kumar Child Clinic, Dwarka, New Delhi, India
Pages 1635-1649 | Received 21 Jul 2020, Accepted 29 Oct 2020, Published online: 03 Dec 2020

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vipin M. Vashishtha. (2021) Is ‘original antigenic sin’ complicating indian vaccination drive against Covid-19?. Human Vaccines & Immunotherapeutics 17:10, pages 3314-3315.
Read now
Michele Gringeri, Giulia Mosini, Vera Battini, Gianluca Cammarata, Greta Guarnieri, Carla Carnovale, Emilio Clementi & Sonia Radice. (2021) Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facility. Human Vaccines & Immunotherapeutics 17:9, pages 2969-2971.
Read now

Articles from other publishers (11)

Anurag Bele, Vasant Wagh & Pratiksha K Munjewar. (2023) A Comprehensive Review on Cardiovascular Complications of COVID-19: Unraveling the Link to Bacterial Endocarditis. Cureus.
Crossref
Jun-Xiang Zhou, Xue Yin & Hao-Jun Liang. (2022) An Effective Platform for SARS-CoV-2 Prevention by Combining Neutralization and RNAi Technology. Chinese Journal of Polymer Science 41:3, pages 327-333.
Crossref
Lan Yao, J Carolyn Graff, Weikuan Gu & Dianjun Sun. (2022) Influenza vaccination may have only minimum or no effect on COVID-19 in the aged population. BMJ Global Health 7:11, pages e010332.
Crossref
Vyankatesh Pidiyar, Ganesh Kumraj, Kafil Ahmed, Syed Ahmed, Sanket Shah, Piyali Majumder, Bhawna Verma, Sarang Pathak & Sushmita Mukherjee. (2022) COVID-19 management landscape: A need for an affordable platform to manufacture safe and efficacious biotherapeutics and prophylactics for the developing countries. Vaccine 40:36, pages 5302-5312.
Crossref
Yaser A. Al Naam, Salah H. Elsafi, Zeyad S. Alkharraz, Thekra N. Almaqati, Ahmed M. Alomar, Ibrahim A. Al Balawi, Arulanantham Z. Jebakumar, Aisha A. Ghazwani, Saleh S. Almusabi, Sattam Albusaili, Fahad A. Mashwal & Eidan M. Al Zahrani. (2022) Factors related to COVID-19 vaccine hesitancy in Saudi Arabia. Public Health in Practice 3, pages 100258.
Crossref
Karolina Sobeczek, Mariusz Gujski & Filip Raciborski. (2022) HPV Vaccination: Polish-Language Facebook Discourse Analysis. International Journal of Environmental Research and Public Health 19:2, pages 914.
Crossref
Edgardo Alania-Torres, Herminio Morillas-Climent, Alexandre García-Escrivá, Paul Vinueza-Buitrón, Inmaculada Poquet-Catalá, Esther Zorio, Ignacio José Sánchez-Lázaro, Emilio Galcerá-Jornet & Alfonso Valle-Muñoz. (2021) Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy. Frontiers in Cardiovascular Medicine 8.
Crossref
Manisha S. Deshpande & Tanushree Banerjee. (2021) A decoy strategy to activate the immune system. IUBMB Life 73:10, pages 1205-1209.
Crossref
Victoria Matyushenko, Irina Isakova-Sivak, Igor Kudryavtsev, Arina Goshina, Anna Chistyakova, Ekaterina Stepanova, Polina Prokopenko, Ivan Sychev & Larisa Rudenko. (2021) Detection of IFNγ-Secreting CD4+ and CD8+ Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2. Viruses 13:8, pages 1490.
Crossref
Salma Bessalah, Samira Jebahi, Naceur Mejri, Imed Salhi, Touhami Khorchani & Mohamed Hammadi. (2021) Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19). 3 Biotech 11:2.
Crossref
Yongping Yang, Wei Shi, Olubukola M. Abiona, Alexandra Nazzari, Adam S. Olia, Li Ou, Emily Phung, Tyler Stephens, Yaroslav Tsybovsky, Raffaello Verardi, Shuishu Wang, Anne Werner, Christina Yap, David Ambrozak, Tatsiana Bylund, Tracy Liu, Richard Nguyen, Lingshu Wang, Baoshan Zhang, Tongqing Zhou, Gwo-Yu Chuang, Barney S. Graham, John R. Mascola, Kizzmekia S. Corbett & Peter D. Kwong. (2021) Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses. Vaccines 9:2, pages 73.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.